期刊文献+

免疫抑制剂在人体器官移植中的应用

原文传递
导出
摘要 随着近年来人体器官移植术的开展,已有很多药物应用于临床从而使移植器官存活并维持良好功能。联合应用硫唑嘌呤(Aza)和泼尼松(Pred)进行肝移植的治疗一直是器官移植抗排斥反应的两大支柱药物。环孢素A(Cyclosporine,CSA;Sandimmune)了二1978年用于肝肾移植,使移植器官的成活率大大提高。为了增加免疫抑制效果,减少药物副作用,
作者 马满玲 刘璐
出处 《伤残医学杂志》 2004年第4期47-49,共3页 Medical Journal of Trauma and Disability
  • 相关文献

参考文献8

  • 1[1]Sato K, Ogawa K, Onumata O, Aso K, Nakayama Y, Yoshida K, Endo T, Kakita A. Cause of death in renal transplant patients: a comparison between azathioprine and ciclosporin[J]. Surg Today. 2001, 31(8) :681~7.
  • 2[2]McIntyre CW, Fluck RJ, Lambie SH.Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment[J]. Clin Nephrol, 2001 Sep, 56(3) : 193~8.
  • 3[3]Nashsn B,Light S. Reduction of acute renal allgraft rejection by daclizumab[J]. Transplantation. 1999, 67(1) : 110.
  • 4[4]Takemoto SK. Maintenance immunosuppression[J]. Clin Transpl. 2000, 481~95.
  • 5[5]Pirsh JD, Miller J, Deierhol MH et al. A comparison of cyclisporine for immunosuppression after cadaveric renal transplantation[J]. Transplation, 1997, 3(7) : 977~983.
  • 6[6]The US. Renal transplant mycophenolate mofeti study group[J]. Transpl- antation, 1994, 6 : 225.
  • 7[7]Palmer SM, Baz MA, Sanders L, Miralles AP, Lawrence CM, Rea JB, Zander DS, Edwards LJ, Staples ED, Tapson VF, Davis RD.Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection[J]. Transplantation, 2001 Jun 27, 71(12):1772~6.
  • 8[8]Cole MS, stellreacht KE, Shi JD, et al. HuM291, a humanized anti-CD3 antibody is immunosuppressive to T cells while echibiting reduced mitogenicity in vitro[J]. Transplation, 1999, 68 : 563.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部